Literature DB >> 10847562

Serum levels of coenzyme Q10 in patients with Alzheimer's disease.

F de Bustos1, J A Molina, F J Jiménez-Jiménez, A García-Redondo, C Gómez-Escalonilla, J Porta-Etessam, A Berbel, M Zurdo, B Barcenilla, G Parrilla, R Enriquez-de-Salamanca, J Arenas.   

Abstract

We compared serum levels of coenzyme Q10 and the coenzyme Q10/cholesterol ratio in 44 patients with Alzheimer's disease (AD), 17 patients with vascular dementia (VD), and 21 matched controls. The mean serum coenzyme Q10 and cholesterol levels and the coenzyme Q10/cholesterol ratio of patients with AD or VD did not differ significantly from those of controls. Coenzyme Q10 levels and coenzyme Q10/cholesterol ratio of AD or VD patients were not correlated with age, age at onset, duration of the disease or scores of the MiniMental State Examination. These results suggest that these values are not related with the risk for AD or VD.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10847562     DOI: 10.1007/s007020050019

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  8 in total

Review 1.  The mitochondrial paradigm for cardiovascular disease susceptibility and cellular function: a complementary concept to Mendelian genetics.

Authors:  David M Krzywanski; Douglas R Moellering; Jessica L Fetterman; Kimberly J Dunham-Snary; Melissa J Sammy; Scott W Ballinger
Journal:  Lab Invest       Date:  2011-06-06       Impact factor: 5.662

2.  Protective efficacy of coenzyme Q10 against DDVP-induced cognitive impairments and neurodegeneration in rats.

Authors:  B K Binukumar; Nidhi Gupta; Aditya Sunkaria; Ramesh Kandimalla; W Y Wani; D R Sharma; Amanjit Bal; Kiran Dip Gill
Journal:  Neurotox Res       Date:  2011-11-15       Impact factor: 3.911

Review 3.  Coenzyme Q10 effects in neurological diseases.

Authors:  H Rauchová
Journal:  Physiol Res       Date:  2021-12-30       Impact factor: 2.139

Review 4.  Blood-Based Biomarkers for Alzheimer's Disease Diagnosis and Progression: An Overview.

Authors:  Angelica Varesi; Adelaide Carrara; Vitor Gomes Pires; Valentina Floris; Elisa Pierella; Gabriele Savioli; Sakshi Prasad; Ciro Esposito; Giovanni Ricevuti; Salvatore Chirumbolo; Alessia Pascale
Journal:  Cells       Date:  2022-04-17       Impact factor: 7.666

5.  Levels of reduced and oxidized coenzyme Q-10 and 8-hydroxy-2'-deoxyguanosine in the CSF of patients with Alzheimer's disease demonstrate that mitochondrial oxidative damage and/or oxidative DNA damage contributes to the neurodegenerative process.

Authors:  Chiaki Isobe; Takashi Abe; Yasuo Terayama
Journal:  J Neurol       Date:  2009-09-27       Impact factor: 4.849

Review 6.  [Coenzyme Q10 in Parkinson's disease. Symptomatic or neuroprotective effects?].

Authors:  A Storch
Journal:  Nervenarzt       Date:  2007-12       Impact factor: 1.214

7.  Coenzyme Q10, Zinc and MDA levels in verruca vulgaris

Authors:  Selma Korkmaz; Fevziye Burcu Şirin; Ijlal Erturan; Halil Ibrahim Büyükbayram; Mehmet Yildirim
Journal:  Turk J Med Sci       Date:  2020-08-26       Impact factor: 0.973

Review 8.  Coenzyme Q10, Ageing and the Nervous System: An Overview.

Authors:  David Mantle; Robert A Heaton; Iain P Hargreaves
Journal:  Antioxidants (Basel)       Date:  2021-12-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.